Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting
Go back to Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting| (NASDAQ: KOD) | Delayed: 37.20 +0.57 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.63 | 52 Week High | $ | |||
| Open | $35.99 | 52 Week Low | $ | |||
| Day High | $37.73 | P/E | N/A | |||
| Day Low | $35.99 | EPS | $ | |||
| Volume | 120,174 | |||||
